MSB 0.54% 92.5¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-103

  1. 12,519 Posts.
    lightbulb Created with Sketch. 3391
    Thanks @dplane - my question was more directed at the FDA (and not the CRL process per se).

    Did the FDA have the capacity (legal, processes, mandate) of offering a conditional approval without going through the CRL or do they need to be asked via the CRL?
    e.g. the FDA can only approve on what it was asked for (on the BLA) and nothing else - or do they have wiggle rooms via these discussions

    BTW - how are you holding up?
    LOL did you see that - by default (HODL) tongue.png
    Last edited by ddwn: 02/10/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
0.005(0.54%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 91.5¢ $1.473M 1.596M

Buyers (Bids)

No. Vol. Price($)
1 32370 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 60258 5
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.